Brought to you by Springer Healthcare. Part of the Springer Nature Group.
Comparative Efficacy of Cabozantinib and Regorafenib for Advanced Hepatocellular Carcinoma
Video Abstract
ePrint
Author(s): Robin K. Kelley et al.
Published: May 18, 2020
Copyright: The Author(s) 2020.
By accessing this content you are agreeing to the following terms and conditions, and certifying that the content provided is for your personal use only.
- The modification, adaptation, manipulation, transformation, translation or creation of derivative works based on the materials is prohibited
- The user may not remove, obscure or modify any copyright or other notices or disclaimers included in the materials
- The user may not transmit in any format the materials to other persons
- Printing copies for distribution for any reason is strictly prohibited
- The user will take all reasonable security measures necessary to prevent unauthorised duplication or unauthorised distribution of the materials
- You accept Springer Healthcare’s Privacy Policy
Disclaimer
The above digital features represent the opinions of the authors. These features consist of a graphical abstract, animated methods video, author-narrated video, plain language summary, slide deck, summary slide, and written scripts of the spoken content in both videos. For a full list of declarations, including funding and author disclosure statements, please see the full text.
